U.S. Health Care REITs Stock News

Lantronix’s Latest Quarter in Focus Lantronix (LTRX) has just posted its Q3 2026 scorecard, with revenue of US$30.2 million and a basic EPS loss of US$0.03, while the trailing 12 month view shows revenue of US$118.6 million and a basic EPS loss of US$0.17. Over recent quarters the company has seen revenue move from US$28.5 million in Q2 2025 to US$30.2 million in Q3 2026, alongside quarterly EPS losses that ranged from US$0.10 to US$0.03. This keeps attention firmly on how quickly margins can...

Ring Energy's Latest Quarter in Focus Ring Energy (REI) opened Q1 2026 with revenue of about US$73.7 million and a basic EPS loss of US$1.06, while trailing 12 month figures show revenue of roughly US$287.4 million and a basic EPS loss of US$1.25. Over recent quarters, the company has seen quarterly revenue move between about US$63.7 million and US$79.6 million, with basic EPS ranging from a profit of US$0.10 to losses such as US$0.25. This puts the latest quarterly loss into clearer context...

Rapport Therapeutics (RAPP) opened Q1 2026 with revenue of US$20 million, a basic EPS loss of US$0.42, and a net income loss of US$19.86 million, providing a clear snapshot of a company still in investment mode. Over the past year, the company has seen quarterly revenue move from US$0 to US$20 million, while quarterly basic EPS loss shifted between US$0.57 and US$0.75 before landing at US$0.42 in the latest quarter. This gives investors a clearer view of how top-line and per-share losses are...

Alto Ingredients (ALTO) opened Q1 2026 with total revenue of US$224.7 million and net income of US$4.0 million, equal to basic EPS of US$0.05 for the quarter. Over the past year, the company has seen quarterly revenue move between US$218.4 million and US$240.9 million, while basic EPS has ranged from a loss of US$0.57 in Q4 2024 to a profit of US$0.29 in Q4 2025. This positions the latest results as part of a broader swing back into positive earnings. The mix of steady revenue levels and...

Warrior Met Coal has completed its Blue Creek mine ahead of schedule, marking a key operational milestone for NYSE:HCC. The project adds meaningful production capacity at a time when analyst sentiment around the company is turning more bullish. The mine completion, together with a swing to profitability, is shaping a fresh phase in Warrior Met Coal’s operating profile. For investors tracking NYSE:HCC, Blue Creek’s early completion comes on top of a very large 5 year return and a 94.8% gain...

Apellis Pharmaceuticals (APLS) opened Q1 2026 with total revenue of US$268.3 million and basic EPS of US$0.15, anchored by net income of US$18.7 million, while its trailing 12 month revenue stood at US$1.1 billion with basic EPS of US$1.05 and net income of US$133.3 million. Over recent quarters the company has seen quarterly revenue range from US$166.8 million to US$458.6 million and basic EPS swing between a loss of US$0.74 and a gain of US$1.71, which places this latest quarter within a...

CrossAmerica Partners (CAPL) opened 2026 with Q1 revenue of US$841.8 million and basic EPS of US$0.26, compared with a trailing twelve month EPS figure of US$1.49 on revenue of about US$3.3 billion. Over the last year, revenue has moved from US$3.7 billion and EPS of US$0.52 on a trailing basis to the latest trailing totals of US$3.3 billion and US$1.49, with net income rising from US$19.9 million to US$56.9 million as margins shifted higher from a low base. See our full analysis for...

Marriott Vacations Worldwide (NYSE:VAC) reported Q1 results alongside a broad restructuring plan that includes leadership changes and cost initiatives. The company outlined asset sales, including a hotel in Cancun, with proceeds expected by 2027 as part of a turnaround effort. Management highlighted early signs of sales recovery, citing an 8% rise in April contract sales and a higher full year contract sales outlook. Marriott Vacations Worldwide focuses on vacation ownership and related...

Kennedy-Wilson Holdings (KW) has just wrapped up FY 2025 with Q4 revenue of US$133.4 million and basic EPS of US$0.21, set against a trailing twelve month revenue base of US$542.5 million and a TTM basic EPS loss of US$0.28. Over recent quarters, the company has seen quarterly revenue move between US$116.7 million and US$142.6 million while basic EPS has swung from a loss of US$0.56 in Q3 2024 to a profit of US$0.21 in Q4 2025. This leaves investors focused on how durable any margin recovery...

Forrester Research (FORR) closed FY 2025 with Q4 revenue of US$101.1 million and basic EPS of a US$1.78 loss, while trailing 12 month figures show total revenue of US$396.9 million and a basic EPS loss of US$6.28 alongside net income losses. Over recent quarters, reported revenue has ranged from US$89.9 million to US$111.7 million, with quarterly basic EPS swinging between a US$4.62 loss and a US$0.21 profit. Over the same period, trailing 12 month net income shifted from a loss of US$5.75...

Fidelity National Financial (FNF) has just wrapped up FY 2025 with Q4 revenue of US$4.1b and a basic EPS loss of US$0.43, while trailing 12 month figures show revenue of US$14.5b and basic EPS of US$2.22. Over recent quarters, the company has seen revenue move from US$3.0b in Q1 2025 to over US$4.0b in Q4, with quarterly EPS ranging from US$0.30 to US$1.33 before the latest loss, creating a mixed picture on profitability. For investors, that combination of solid top line, uneven EPS and...

Chegg (CHGG) has just posted its FY 2025 numbers, with fourth quarter revenue of US$72.7 million and a basic EPS loss of US$0.30, while trailing twelve month revenue came in at US$376.9 million with a basic EPS loss of US$0.96. Over recent quarters, revenue has moved from US$143.5 million in Q4 2024 to US$121.4 million in Q1 2025, US$105.1 million in Q2 2025, US$77.7 million in Q3 2025 and US$72.7 million in Q4 2025, alongside quarterly basic EPS losses ranging between US$0.06 and US$0.33...

Lucky Strike Entertainment (LUCK) just posted Q2 2026 results with revenue of US$306.9 million and a basic EPS loss of US$0.11, alongside net income excluding extra items of a US$15.1 million loss, keeping the focus squarely on how quickly the business can close the gap to profitability. The company has seen quarterly revenue move from US$300.1 million in Q2 2025 to US$306.9 million in Q2 2026, while basic EPS has shifted from a profit of US$0.17 to a loss of US$0.11 over the same period,...

LTC Properties (LTC) has just wrapped up FY 2025 with fourth quarter revenue of US$82.5 million, basic EPS of US$2.14, and funds from operations of US$34.9 million, giving investors a clear view of its latest run rate. Over the past year, revenue across the trailing twelve months moved from US$201.6 million to US$257.6 million, while basic EPS over the same window went from US$2.07 to US$2.54. This sets the backdrop for how you might think about the current report and its implications for...

Matador Resources FY 2025 earnings snapshot Matador Resources (MTDR) has just wrapped up FY 2025 with fourth quarter revenue of US$1,008.7 million and basic EPS of US$1.55, alongside net income from ongoing operations of US$192.5 million. Across the year, the company has seen quarterly revenue range from US$852.5 million to US$1,008.7 million, with EPS between US$1.21 and US$1.92, giving investors a clear line of sight on how the top and bottom line have translated into profit over time. With...

Vital Farms has reported past Q1 2026 results showing sales rising to US$187.16 million from US$162.19 million, but swinging from a US$16.9 million profit to a US$1.52 million net loss alongside an employee stock plan shelf registration of about US$26.88 million. At the same time, Vital Farms is winding down its butter line, managing egg oversupply, and facing multiple lawsuits tied to alleged ERP-related disclosure issues, all of which could influence how investors view its core egg-focused...

Curious whether BrightSpring Health Services at US$52.74 is offering value or just riding hype? This article walks you through what the current price could mean for you as an investor. The stock has returned 9.5% over the past week, 21.2% over the last 30 days, 37.3% year to date and 128.9% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent attention around BrightSpring Health Services has centered on its position in the...

If you are wondering whether Six Flags Entertainment is attractively priced today or a potential value trap in disguise, this article breaks down what the current share price is really offering you. The stock last closed at US$19.69, with returns of 9.3% over the past week, 10.1% over the past month, 27.1% year to date, and a 45.5% decline over the past year as well as 52.2% and 54.1% declines over the last 3 and 5 years. Recent headlines around Six Flags Entertainment have focused on its...

A federal judge has allowed key investor fraud claims against Scotts Miracle-Gro (NYSE:SMG) to proceed, focusing on alleged misstatements around demand, inventory, and the Hawthorne cannabis unit. The ruling keeps senior management and the company under legal scrutiny, extending an ongoing securities lawsuit rather than dismissing it outright. This development adds a layer of litigation and governance risk that sits alongside existing discussions of earnings, debt, and recovery efforts. For...

The RMR Group Inc. has reported past second-quarter 2026 results, with sales rising to US$5.1 million while revenue fell to US$145.63 million, and quarterly net income declining to US$1.01 million, or US$0.05 per diluted share, compared with the prior year period. Over the first six months of fiscal 2026, higher sales but lower revenue coincided with net income improving to US$13.2 million, highlighting a contrast between weaker quarterly profitability and stronger year‑to‑date earnings. We...

Wondering if Robinhood Markets at around US$79 per share is still compelling value or if the easy gains are behind it? This article breaks down what the current price really reflects. The stock has been volatile recently, with an 11% return over the last 7 days, 13.3% over the last 30 days, a 31.4% decline year to date, and a 58.1% return over the last year, which can shift how the market is thinking about both opportunity and risk. Recent coverage has focused on Robinhood's evolving role in...

What recent moves in Veradermics (MANE) might be telling you Veradermics (MANE) has drawn attention after a sharp month return of about 72% and a very large past 3 months move, putting its clinical stage dermatology pipeline and valuation in sharper focus for investors. See our latest analysis for Veradermics. The recent 72% 30 day share price return and very large 90 day move sit alongside a 190.78% year to date share price return, which points to strong upward momentum despite a 4.38% one...

Pool Corporation (NasdaqGS:POOL) has announced the immediate departure of CEO Peter D. Arvan. John B. Watwood has been appointed as the new President and CEO, with John E. Stokely becoming Executive Chair. The company has postponed its upcoming Investor Day following the leadership change. Pool enters this leadership transition after a period of weak share price performance, with NasdaqGS:POOL at $188.09 and showing a 10.3% decline over the past week and 35.2% decline over the past year...

What recent performance signals for Omeros (OMER) Without a single defining headline driving trading, Omeros (OMER) has still drawn attention after a strong month and past 3 months, alongside sizeable 1 year and 3 year total returns. At a recent price of $14.83 and a market cap of about $1.06b, the stock reflects a clinical stage pipeline built around immunologic and rare disease programs rather than current product revenue. See our latest analysis for Omeros. For context, Omeros has paired a...